IIM
KNSA icon

INTECH Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

INTECH Investment Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477K Buy
+7,464
New +$387K ﹤0.01% 1367
2025
Q2 		– Sell
-28,035
Closed -$623K – 2572
2025
Q1 		$623K Buy
28,035
+5,033
+22% +$104K 0.01% 1492
2024
Q4 		$455K Buy
+23,002
New +$525K ﹤0.01% 1618

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

INTECH Investment Management's KNSA Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 7,464 shares worth $477K. The stake represents ﹤0.01% of the portfolio and ranks #1367 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in KNSA as recently as Q1 2025.

INTECH Investment Management first reported a position in KNSA in Q4 2024 and has held it in 3 quarters since. The position peaked at $623K in Q1 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • INTECH Investment Management held 7,464 shares of Kiniksa Pharmaceuticals worth $477K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new INTECH Investment Management position in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1367 holding.
  • INTECH Investment Management first reported a position in Kiniksa Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • INTECH Investment Management's Kiniksa Pharmaceuticals position peaked at $623K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.